Sitafloxacin monotherapy was non-inferior to doxycycline–rifampicin for treating acute uncomplicated brucellosis, and showed a favorable safety and tolerability profile. Thus, sitafloxacin monotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results